PARTNERS
Backed by Leading institutions
A breakthrough mammograph for early detection of breast cancer
Letsee Imaging is developing advanced imaging solutions, to provide every woman & man access to early and most accurate breast cancer detection. We are convinced that our technology will be the next gold reference in mammography.
HOW IT WORKS
Key features about mammography
Breast cancer is the first cause of death for women. Mammography remains the reference diagnostics.
Breast cancer mortality in high-income countries dropped by 40% between the 1980s and 2020, thanks to the organized screening: 1 mammography every 2 years after 50 years.
1 in 8 women
1/8 women will develop breast cancer in their lifetime. Half of all breast cancers occur in women with no specific risk factors.
2 300 000 women
2.3 millions women diagnosed with breast cancer in the world in 2022.
670 000 deaths
670 000 deaths annually worldwide in 2022. First cause of death for women.
6 / 10
6 / 10 cancers detected at an early stage.
TEAM
A team of excellence
Letsee Imaging, a spinoff from CNRS, was founded in November 2023 by Ombeline de La Rochefoucauld and Philippe Zeitoun, after 8 years of collaboration on X-rays imaging systems. Letsee Imaging is built on a skilled and dedicated team, advised by an internationally recognized strategic committee composed of entrepreneurs, radiologists, and scientists. Together, they combine expertise and innovation to advance healthcare.
Credit : HEC Record